194 related articles for article (PubMed ID: 15582885)
41. [Secondary debulking operation in ovarian cancer].
Jänicke F; Schattenmann G; Kuhn W; Graeff H; Siewert JR
Chirurg; 1994 Jan; 65(1):10-7. PubMed ID: 8149793
[No Abstract] [Full Text] [Related]
42. [Recytoreductive surgery for recurrent epithelial ovarian cancer].
Fu CW; Shen K; Wu M; Huang HF; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):661-3. PubMed ID: 14728850
[TBL] [Abstract][Full Text] [Related]
43. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.
Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D
Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375
[TBL] [Abstract][Full Text] [Related]
44. Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients.
Sehouli J; Richter R; Braicu EI; Bühling KJ; Bahra M; Neuhaus P; Lichtenegger W; Fotopoulou C
J Surg Oncol; 2010 Nov; 102(6):656-62. PubMed ID: 20734422
[TBL] [Abstract][Full Text] [Related]
45. Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer.
Benedetti Panici P; De Vivo A; Bellati F; Manci N; Perniola G; Basile S; Muzii L; Angioli R
Ann Surg Oncol; 2007 Mar; 14(3):1136-42. PubMed ID: 17195909
[TBL] [Abstract][Full Text] [Related]
46. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
47. [Up-date on cytoreductive surgery in the management of advanced ovarian cancer].
Angioli R; Palaia I; Damiani P; Montera R; Benedetti Panici P
Minerva Ginecol; 2006 Dec; 58(6):459-70. PubMed ID: 17108876
[TBL] [Abstract][Full Text] [Related]
48. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
49. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
[TBL] [Abstract][Full Text] [Related]
50. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.
Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
Minerva Ginecol; 2006 Oct; 58(5):393-403. PubMed ID: 17006426
[TBL] [Abstract][Full Text] [Related]
51. Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study.
Eisenkop SM; Friedman RL; Wang HJ
Cancer; 1995 Nov; 76(9):1606-14. PubMed ID: 8635065
[TBL] [Abstract][Full Text] [Related]
52. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent advanced ovarian cancer: a prospective study.
Spiliotis J; Vaxevanidou A; Sergouniotis F; Lambropoulou E; Datsis A; Christopoulou A
J BUON; 2011; 16(1):74-9. PubMed ID: 21674853
[TBL] [Abstract][Full Text] [Related]
53. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
Cree IA; Kurbacher CM; Lamont A; Hindley AC; Love S;
Anticancer Drugs; 2007 Oct; 18(9):1093-101. PubMed ID: 17704660
[TBL] [Abstract][Full Text] [Related]
54. Role of surgery in ovarian carcinoma.
Fader AN; Rose PG
J Clin Oncol; 2007 Jul; 25(20):2873-83. PubMed ID: 17617518
[TBL] [Abstract][Full Text] [Related]
55. Diagnosis and management of epithelial ovarian cancer.
Bhoola S; Hoskins WJ
Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive approach to advanced primary and recurrent ovarian cancer: a personal experience.
Carmignani CP; Sugarbaker PH
Expert Rev Anticancer Ther; 2004 Jun; 4(3):477-87. PubMed ID: 15161446
[TBL] [Abstract][Full Text] [Related]
57. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
[TBL] [Abstract][Full Text] [Related]
58. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum.
Gronlund B; Lundvall L; Christensen IJ; Knudsen JB; Høgdall C
Eur J Surg Oncol; 2005 Feb; 31(1):67-73. PubMed ID: 15642428
[TBL] [Abstract][Full Text] [Related]
59. Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial.
Crawford SC; Vasey PA; Paul J; Hay A; Davis JA; Kaye SB
J Clin Oncol; 2005 Dec; 23(34):8802-11. PubMed ID: 16314640
[TBL] [Abstract][Full Text] [Related]
60. [Treatment of epithelial ovarian cancer].
Langmár Z; Csömör S
Orv Hetil; 2006 Aug; 147(34):1627-32. PubMed ID: 17017677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
